In the setting of IPF therapeutics, it has been used mainly as a bridge to transplantation [ 74].
The requirement of having two attachment points is of course antithetical to the exploration of chain-terminating nucleoside analogues, such as 2′,3′-dideoxynucleoside analogues; thus there is a bias against finding these types of therapeutics in this set.
Clinically relevant animal models of disease are essential for the development of therapeutics, and guidelines set out by the stroke research community aim to improve the translation from preclinical research to clinical trials (Fisher et al., 2009).
Our data contribute to the understanding of temporal heterogeneity of HGSOC immune microenvironment and have implications for selection of samples for biomarker testing in the setting of immune-targeting therapeutics.
We therefore searched the Open Chemical Repository Collection, a diverse set of more than 200,000 compounds (Developmental Therapeutics Program, National Cancer Institute, Bethesda), for the presence of N-hydroxyimides.
Rhodes Professor of Therapeutics and Cancer Medicine, University of Oxford.
These subtypes can highly benefit from multiple lines of therapeutics.
Oral delivery of therapeutics is extremely challenging.
Whilst it is an imperfect set of models, EAE can be used to identify pathogenic mechanisms and therapeutics.
This will allow us to identify a broad set of virulence factors which, in turn, may be used in the identification of novel therapeutics.
